When it opens in early 2025, the Jack & Sheryl Morris Cancer Center will bring together advanced resources for research, prevention and clinical care at a single location.
The Jack & Sheryl Morris Cancer Center now under construction in New Brunswick is a significant project in an investment initiative designed to create an integrated network of state-of-the-art cancer care facilities throughout New Jersey.
Developed by RWJBarnabas Health (RWJBH) and Rutgers Cancer Institute of New Jersey in partnership with the New Brunswick Development Corporation, the new $750 million, 12-story, 510,000-square-foot facility will be the state’s first and only freestanding cancer hospital.
The center, named in recognition of the philanthropic leadership of Jack Morris, who has been a longtime supporter and pillar in New Brunswick development, and his wife, Sheryl, will include the wide-ranging advanced oncology care services offered by Rutgers Cancer Institute and RWJBH all under one roof. Greatly enhancing the patient experience and providing further ease of access, the new facility is slated to open in early 2025. The new cancer center brings together all facets of research, prevention and clinical care at a single location and will provide a model for cancer care delivery. Patients at the center will be able to receive a range of inpatient and outpatient cancer care, including advanced imaging services as well as radiation therapy, chemotherapy and surgical treatments. Wellness, prevention and education resources will also be available for the community, patients, caregivers and families.
Services at the center will follow a multidisciplinary care model in which cancer specialists throughout RWJBH and Rutgers Cancer Institute collaborate to devise the best treatment plan for each patient, including clinical trials, immunotherapy and precision medicine.
The center will include state-of-the-art laboratories where teams of scientists will study cancer and develop new treatments. Having labs on-site will help translate lab discoveries directly to the clinical settings at Rutgers Cancer Institute and across the RWJBH system, enhancing the tailoring of patient treatments and expediting the collection of research data.
Other key cancer centers under construction are the Cancer Center at Cooperman Barnabas Medical Center (CBMC) and Monmouth Medical Center’s Vogel Medical Campus. The $225 million Cancer Center at CBMC in Livingston will be an outpatient center serving as a regional hub for integrated cancer services. The $200 million Vogel outpatient center will offer comprehensive cancer services and same-day surgery, onsite specialty services and advanced diagnostic imaging.
